Literature DB >> 20816427

Migraine general aspects.

Michael A Moskowitz1, M Gabriella Buzzi.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20816427     DOI： 10.1016/S0072-9752(10)97021-8

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN： 0072-9752


× No keyword cloud information.
  5 in total

1.  Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment.

Authors:  Erika Fh Saunders; Aubrey Reider; Gagan Singh; Alan J Gelenberg; Stanley I Rapoport
Journal:  Bipolar Disord       Date:  2015-10-01       Impact factor: 6.744

2.  Reconsidering Dietary Polyunsaturated Fatty Acids in Bipolar Disorder: A Translational Picture.

Authors:  Erika F H Saunders; Christopher E Ramsden; Mostafa S Sherazy; Alan J Gelenberg; John M Davis; Stanley I Rapoport
Journal:  J Clin Psychiatry       Date:  2016-10       Impact factor: 4.384

3.  Metabolomics Strategy Using High Resolution Mass Spectrometry Reveals Novel Biomarkers and Pain-Relief Effect of Traditional Chinese Medicine Prescription Wu-Zhu-Yu Decoction Acting on Headache Modelling Rats.

Authors:  Ran Liu; Huarong Xu; Xiaowen Zhang; Xiaotong Wang; Ziyue Yuan; Zhenyu Sui; Dong Wang; Kaishun Bi; Qing Li
Journal:  Molecules       Date:  2017-12-18       Impact factor: 4.411

4.  Effects of LPS on P2X3 receptors of trigeminal sensory neurons and macrophages from mice expressing the R192Q Cacna1a gene mutation of familial hemiplegic migraine-1.

Authors:  Alessia Franceschini; Swathi K Hullugundi; Arn M J M van den Maagdenberg; Andrea Nistri; Elsa Fabbretti
Journal:  Purinergic Signal       Date:  2012-07-27       Impact factor: 3.765

5.  The mechanism of functional up-regulation of P2X3 receptors of trigeminal sensory neurons in a genetic mouse model of familial hemiplegic migraine type 1 (FHM-1).

Authors:  Swathi K Hullugundi; Michel D Ferrari; Arn M J M van den Maagdenberg; Andrea Nistri
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.